The GRSC is a federally incorporated charitable organization established to raise funds to find a cure for glaucoma. (CRA Charitable Registration Number 889178695 RR 0001).
The GRSC provides one year grants for independent basic and clinical research into all aspects of glaucoma. Grants are awarded for eligible research projects recommended by the Scientific Advisory Committee and approved by the GRSC Board. Only two renewals of projects previously funded by GRSC will be considered.
The Board of Directors of the GRSC determines the amount of the annual funding envelope at the start of the granting process. The number of grants to be awarded and the amount of each grant are dependent upon the quality of the proposals and the availability of GRSC funds. Research proposals will not necessarily be funded, either in whole or in part. The maximum amount of funding is $20,000.000 per research proposal.
If funding is obtained from other funding organizations during the period of the grant to accomplish the same research objectives, a report must be submitted to GRSC and each other funding organization, describing how the additional funds from the other organization will be used.
Only researchers with a Canadian university or academic hospital appointment are eligible to receive funding. Funding may be provided to students in an academic research program as long as the project is under supervision by a preceptor and the results are to form part of a Masters or PHD thesis. Funding may be provided for post doctoral student studies and for clinical research fellowships on the condition that the research is supervised by a clinician researcher of national standing. Funding may also be provided for trainees if they meet the following criteria:
Previous grant recipients must have provided GRSC with up-to-date reports, as outlined in the terms of this agreement, in order to be eligible for renewed funding.
Before funding can be considered, all clinical or animal based research must have prior or pending research ethics board approval. The name and address of the ethics committee must be supplied.
Applicants are invited to submit their applications online using our module found at www.glaucomaresearch.ca/research-portal by Friday December 18, 2020. For further information, please call Suzanne Marshall, Administrator, Glaucoma Research Society of Canada at 416-483-0200 or 1-877-483-0204 or email firstname.lastname@example.org. All applicants will be notified by email, no later than May 31, 2021, if GRSC is able to fund their proposal or not.
All applications are reviewed and ranked using an independent peer review process coordinated by the Chair of the GRSC Scientific Advisory Committee. The independent Scientific Advisory Committee reviews the outcomes of the peer review process and makes recommendations for grant approvals to the Board of Directors of the GRSC.
Grant cheques are payable only to Canadian charitably designated public institutions, such as academic hospitals or universities.
Grants may not be deposited into personal accounts, to business accounts or to the accounts of foundations.
The Principal Investigator, Co-principal Investigator and University/Hospital Signing Authority must complete, sign and return the SIGNATURES for Release page to GRSC prior to cheque being released.
The one year granting period starts on the date the grant cheque is cashed by the recipient’s institution.
The Principal Investigator must use the grant funds solely for the purpose of glaucoma research and glaucoma research support as set out in the application that was submitted.
If the funds cannot be used in that manner due to the pandemic or for other emergencies, then either:
Grant funds may not be used for salary support to the Principal Investigator, or for the personal use of the Principal Investigator or any member of the project research team.
Policies from the relevant institutions regarding grant disbursement to researchers will apply.
The Principal Investigator agrees that any portion of the grant that has not been used during the granting period in accordance with proposal must be repaid to the GRSC within four months of termination of the granting period.
The Principal Investigator’s institution through which the funds were flowed must provide the GRSC with a copy of the Fund Utilization Report outlining how the funds were used.
Any unused funds must be returned to the GRSC by the Principal Investigator and/or by the institution.
Each Principal Investigator must provide a Final Report of their research to the GRSC within 6 weeks of the end of the granting period. Future funding can only be granted if all outstanding final reports and/or progress reports have been received.
The Principal Investigator may be asked to provide information for use by the GRSC in media such as newsletters, news releases and the GRSC web site. The GRSC will advise the Principal Investigator before any such materials are made public.
The GRSC must be acknowledged in all publications including abstracts and presentations about the research arising from the grant. Three copies of published abstracts and scientific articles must be forwarded to the GRSC.
If any investigator or institution fails to comply with the terms of this agreement, the GRSC will notify the investigators or institution, suspend further payments and claim for recovery of any funds not applied in accordance with the terms of this agreement.